Last Updated: 24/11/2025

Seasonal Malaria Chemoprevention expansion in Chad

Objectives

This project will expand seasonal malaria chemoprevention (SMC) campaign in Chad from 12 to 43 districts.

Principal Institution

Malaria Consortium, United Kingdom

Rationale and Abstract

Malaria Consortium uses funding for their SMC program to, among other things, buy the medicines used in SMC, train community distributors to deliver the medicines door-to-door, and conduct monitoring to understand what proportion of children are reached. Chad has 135 health districts eligible for SMC, according to the national malaria program’s 2022 stratification exercise. Currently, 51 districts are funded for SMC campaigns in 2025 and 2026, which leaves 84 SMC-eligible districts unfunded. This grant will enable Malaria Consortium to deliver SMC during the 2026 and 2027 malaria seasons in 31 districts that have not previously received SMC, while continuing support through 2027 in the 12 districts we previously provided funding for through 2026. The expansion will increase Malaria Consortium’s geographic scope in Chad from 12 to 43 districts across five regions.

Date

Jun 2025

Total Project Funding

$10.43M

Funding Details
Project Site

Chad

SHARE
SHARE